Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Schram

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Blood|March 12, 2015
How I treat hemophagocytic lymphohistiocytosis in the adult patientAlison M Schram, Nancy Berliner
Molecular Cancer Therapeutics|September 16, 2024
Emerging Tumor-Agnostic Molecular TargetsDedipya Bhamidipati, Alison M Schram
Archives of Dermatology|February 22, 2012
Neurogenic rosacea treated with endoscopic thoracic sympathectomyAlison M Schram, William D James
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Tumor-Agnostic AKT Inhibition: Is It Time to AKT?Ricardo Dahmer Tiecher, Alison M Schram
Cancer Discovery|June 4, 2017
Quantifying the Benefits of Genome-Driven OncologyAlison M Schram, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Plos Medicine|February 22, 2017
Precision oncology: Charting a path forward to broader deployment of genomic profilingAlison M Schram, Michael F Berger, David M Hyman
Annual Review of Medicine|November 10, 2017
Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven OncologyJessica J Tao, Alison M Schram, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Genome-Driven Paradigm for the Development of Selective Fibroblast Growth Factor Receptor InhibitorsAlison M Schram, Martin H Voss, David M Hyman
The New England Journal of Medicine|February 24, 2017
Niraparib in Recurrent Ovarian CancerAlison M Schram, Carol A Aghajanian, David M Hyman
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Blood|March 12, 2015
How I treat hemophagocytic lymphohistiocytosis in the adult patientAlison M Schram, Nancy Berliner
Molecular Cancer Therapeutics|September 16, 2024
Emerging Tumor-Agnostic Molecular TargetsDedipya Bhamidipati, Alison M Schram
Archives of Dermatology|February 22, 2012
Neurogenic rosacea treated with endoscopic thoracic sympathectomyAlison M Schram, William D James
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Tumor-Agnostic AKT Inhibition: Is It Time to AKT?Ricardo Dahmer Tiecher, Alison M Schram
Cancer Discovery|June 4, 2017
Quantifying the Benefits of Genome-Driven OncologyAlison M Schram, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Plos Medicine|February 22, 2017
Precision oncology: Charting a path forward to broader deployment of genomic profilingAlison M Schram, Michael F Berger, David M Hyman
Annual Review of Medicine|November 10, 2017
Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven OncologyJessica J Tao, Alison M Schram, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Genome-Driven Paradigm for the Development of Selective Fibroblast Growth Factor Receptor InhibitorsAlison M Schram, Martin H Voss, David M Hyman
The New England Journal of Medicine|February 24, 2017
Niraparib in Recurrent Ovarian CancerAlison M Schram, Carol A Aghajanian, David M Hyman
Pageof 8